HF with mildly reduced EF is gone, stages are updated, and new classifications for medical and interventional therapies are ...
Investigators stressed that the method is simple, doesn’t require ultrasound, and can be done with existing cath lab ...
Terminology shifts to “decompensated heart failure,” introducing an initial–stabilization–pre/postdischarge framework and ...
Updated AHA and ASA guidelines emphasize interprofessional care and inpatient rehabilitation facilities for poststroke recovery.
Results from the phase 3 PAPILLON study show that first-line amivantamab plus carboplatin-pemetrexed ...
Positive results from the DESTINY-Lung04 Phase III trial showed AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a statistically significant and clinically ...
Despite notable advancements in the acute and long-term management, coronary artery disease and myocardial infarction (MI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results